| Financial Year |
March 31 2023 |
| Monetary Funds |
15,554,422,004.00 |
| Held-for-trading Financial Assets |
7,244,076,067.00 |
| Notes Receivable |
3,000,000.00 |
| Accounts Receivable |
140,617,186.00 |
| Advances to Suppliers |
265,680,585.00 |
| Other Receivables |
125,487,954.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,607,622,462.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,925,120,344.00 |
| Total Current Assets |
31,866,026,602.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
364,245,750.00 |
| Investment Properties |
28,151,792.00 |
| Fixed Assetes |
10,903,086,312.00 |
| Under-construction Projects |
462,587,627.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,525,985,345.00 |
| R&D expenses |
-- |
| Goodwill |
1,307,103,982.00 |
| Long-Term Deferred and Prepaid Expenses |
98,264,362.00 |
| Deferred Income Tax Assets |
2,333,125,543.00 |
| Other Non-Current Assets |
96,484,342.00 |
| Sub-Total of Non-Current Assets |
18,270,209,450.00 |
| Total Assets |
50,136,236,052.00 |
| Short-Term Loans |
221,057,001.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
303,595,557.00 |
| Accounts Payable |
4,192,013,413.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,120,590,650.00 |
| Taxes Payable |
1,010,138,556.00 |
| Interest Payable |
-- |
| Dividend Payable |
37,602,600.00 |
| Other payables |
3,774,900,746.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,640,161.00 |
| Other Current Liabilities |
167,125,964.00 |
| Sub-Total of Current Liabilities |
18,038,026,552.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
16,264,266.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
220,139,911.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,328,534,085.00 |
| Total Liabilities |
22,366,560,637.00 |
| Paid-In Capital(Or Share Stock) |
1,364,232,790.00 |
| Capital Surplus |
4,213,689,069.00 |
| Surplus Reserve |
1,400,704,380.00 |
| LESS:Treasury Stock |
171,854,660.00 |
| Undistributed Profits |
19,979,631,235.00 |
| Minority Stockholder's Interest |
760,050,597.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
27,009,624,818.00 |
| Owner's Equity（Stockholder's Equity） |
27,769,675,415.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
50,136,236,052.00 |
